Guardant Health

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$281,266
$265,196
$232,088
$203,471
Gross Profit
181,774
171,609
150,883
128,748
EBITDA
-118,991
-82,238
-88,836
-83,842
EBIT
-129,041
-91,646
-98,878
-94,078
Net Income
-128,494
-92,725
-99,899
-95,159
Net Change In Cash
281,266
265,196
232,088
203,471
Free Cash Flow
-41,932
-45,763
-65,934
-67,148
Cash
378,203
580,013
629,143
698,572
Basic Shares
128,657
125,304
124,114
123,871

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$982,021
$739,016
$563,948
$449,538
Gross Profit
633,014
449,217
336,896
293,213
EBITDA
-373,907
-390,121
-433,305
-614,910
EBIT
-413,643
-432,508
-476,186
-650,872
Net Income
-416,277
-436,373
-479,449
-654,588
Net Change In Cash
982,021
739,016
563,948
449,538
Cost of Revenue
-348,740
Free Cash Flow
-233,066
-274,943
-345,461
-386,924
Cash
378,203
525,540
1,133,537
141,647
Basic Shares
125,374
122,745
111,988
102,178

Earnings Calls

QuarterEPS
2025-12-31
-$0.50
2025-09-30
-$0.39
2025-06-30
-$0.44
2025-03-31
-$0.49